Imatib 400mg 10 Tablets

Babies: Safe if prescribed. Lactating mothers: It is not recommended to use in breastfeeding as imatib tablet is secreted in human milk. It is advised that lactating women should not breastfeed during treatment and one month after the last dose. Pregnancy: It is not recommended to use in pregnant women as it may cause harm to the fetus.
Please consult your doctor. Driving: This medication may cause decreased mental alertness, blurred vision, drowsiness, and dizziness. It is advised not to drive while on this medication.
Alcohol: Avoid alcohol consumption while taking imatib tablets as it may increase the risk of drowsiness and dizziness. Liver: Imatib tablets should be used in caution with patients suffering from liver disease. You may require a dose adjustment and regular monitoring of liver function.
Seek doctor advice before using this medication. Kidney: Imatib tablets should be used in caution with patients suffering from kidney disease.
You may require a dose adjustment and regular monitoring of kidney function. Seek a doctor's advice before using this medication.
.

Diarrhoea Nausea and vomiting Mouth sores Loss of appetite Altered sense of taste Heartburn and indigestion Joint pain, stiffness, and swelling Burning or tingling sensation of hands and feet Trouble sleeping Skin rash Hair loss Swelling or the hands, feet, ankle, and lower legs Shortness of breath Fast/irregular heart beat Unusual bleeding or bruising Stomach pain Headache Dizziness Drowsiness Low blood count.

Imatib tablet is an antineoplastic agent. It works by slowing or stopping cancer cell growth.
Imatib can also be used to treat immune system problems (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). .

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• It can make you dizzy or cause your vision to blur. Do not drive or perform any other task that requires concentration until you have determined how it affects you. • Water retention and swelling are common imatib tablet side effects.
Notify your doctor if you experience unusual rapid weight gain. • Do not change the dose or stop using without first consulting your doctor. • Inform your doctor about all medications you are taking, including otc medications and dietary supplements. • Regular blood tests may be ordered by your doctor to monitor your liver function and the number of blood cells in your blood..

Contraindicated • Imatib + Eliglustat: Concurrent use may lead to increased risk of eligustat exposure and subsequent prolongation of qt-intervalxx • Imatib + Filbanserin: Concurrent use may lead to increased exposure to filbanserin and increased adverse effects such as hypotension, syncope, sedation • Imatib + Lomitapide: Concurrent use may lead to increased exposure to lomitapide • Imatib + Measels virus vaccine: Concurrent use may lead to increase risk of infection by live vaccine • Imatib + Rotavirus vaccine: Concurrent use may lead to increase risk of infection by live vaccine • Imatib + Rubella virus vaccine: Concurrent use may lead to increase risk of infection by live vaccine • Imatib + Varcella virus vaccine: Concurrent use may lead to increase risk of infection by live vaccine • Imatib + Zoster vaccine: Concurrent use may lead to increase risk of infection by live vaccine Serious • Imatib + Abametapir: Concurrent use may lead to increased exposure to cyp3a4 substrate • Imatib + Acalabrutinib: Concurrent use may lead to increased acalabrutinib exposure and increased risk of toxicity • Imatib + Acetaminophen: Concurrent use may lead to increased acetaminophen plasma concentrations • Imatib +Adenovirus vaccine: Concurrent use may lead to increased risk of infection by the live vaccine • Imatib +Alfentanil: Concurrent use may lead to increased plasma concentrations of alfentanil and increased risk of respiratory depression Monitor closely • Imatib + Abemaciclib: Concurrent use may lead to increased abemaciclib plasma concentrations • Imatib + Amlodipine: Concurrent use may lead to increased amlodipine exposure and increased risk of imatib toxicity • Imatib + Bromocriptine: Concurrent use may lead to increased bromocriptine concentrations • Imatib + Cyclosporine: Concurrent use may lead to increased exposure of bcrp substrates • Imatib +Guanfacine: Concurrent use may lead to increased guanofacine exposure.